News Releases


Oct 18, 2016

Insmed Announces Publication of Phase 2 Study of ARIKAYCE in Treatment-Refractory Nontuberculous Mycobacterial Lung Disease

Oct 5, 2016

Insmed Announces Worldwide License Agreement with AstraZeneca for Oral DPP1 Inhibitor

Sep 27, 2016

Insmed Appoints Roger Adsett as Chief Commercial Officer

Sep 8, 2016

Insmed to Participate at September Investor Conferences

Aug 31, 2016

Insmed Announces Upcoming Presentations at European Respiratory Society 2016 International Congress

Aug 4, 2016

Insmed Reports Second Quarter 2016 Financial Results

Jun 8, 2016

Insmed Announces Withdrawal of Marketing Authorization Application for ARIKAYCE™ in Europe

May 9, 2016

Insmed to Present at the Bank of America Global Healthcare Conference

May 5, 2016

Insmed Reports First Quarter 2016 Financial Results

May 3, 2016

Insmed Announces Upcoming Presentations at the American Thoracic Society 2016 International Meeting